Carnot I2C (Innovation Chimie Carnot)
The Carnot Institute I2C brings together 8 research entities from Normandy on the 2nd territory of the chemical industry in France.
With a strong expertise in synthesis, analysis and formulation, I2C capitalizes on this chemistry value chain as a privileged partner to support innovation for the pharmaceuticals, fine chemicals, food, bioressources, cosmetics, energy and environmental sectors industries.
Key figures
Permanent staff (full-time equivalent) | 261 |
PhD Students | 107 |
Global budget | 32 M€ |
Partnership incomes with industry | 3,8 M€ |
Contact
Institut Carnot
Innovation Chimie Carnot I2C
Normandie Université
Esplanade de la Paix
CS 14032
Caen Cedex 5
Vincent LEVACHER
Director
06 40 41 89 44
vincent.Levacher[a]insa-rouen.fr
Présentation
3 skill centers working in synergy
1. Synthesis department: An unique expertise to support innovation in synthesis in the sectors of pharmaceutical chemistry and fine chemicals, agrifood and cosmetics.
- Methodologies in synthesis with improved performances and extended applications
- Sustainable chemical synthesis
- New molecular tools for diagnosis and therapies monitoring (fluorescent and MRI probes, bimodal probes, radiotracers for PET imaging…)
- New drug candidates (design, synthesis, screening and drugability) and biopharmaceuticals
2. Analytical chemistry department: Cutting-edge equipment and innovative methodologies to address the analytical challenges of companies.
- Qualitative and quantitative analysis methods dedicated to chemistry, materials and biomolecules
- Multidimensional analyses for physicochemical and structural characterization of complex matrices
- Statistical tools for data processing as part of global analytical approaches
- Miniaturized systems for on-site analysis
- Optical and molecular imaging, tomography, AFM
- Quantum chemistry and molecular mechanics
3. Formulation/polymers department: A set of skills at the frontiers of chemistry and physico-chemistry for formulators to design and optimize innovative products with controlled properties
- Solutions, dispersions, emulsions and gels (processing, technological additives…)
- Galenic formulation and drug delivery, crystallization and polymorphism
- Colloids and dispersed systems (rheology, mixtures, ingredients, organoleptic properties)
- Polymers, biopolymers and composites with controlled properties (active, adaptive, functional polymers, nanocomposites)
Target markets
- Pharmaceuticals and fine chemicals
- Agrifood and bioressources
- Cosmetics
- Energy and environment
Easier access to top level facilities
- C2I-OrgA (Methodology in synthesis and analysis
- Medicinal chemistry platform and chemical Library
- Cyceron (Biomedical imaging)
- Pissaro Proteomics Platform
- Cosmetomic
- Materials CNRT
[18F]Fludarabine :
An innovative radiopharmaceutical
for lymphoma imaging in clinical trial.
Some major equipments
- Mass spectrometry
- High resolution NMR
- Separative sciences
- Imaging
Know-how
- Synthetic chemistry – Catalysis- Innovative technologies – Medicinal chemistry, bio-organic and radiosynthesis - Synthesis of recombinant proteins in plants and microalgae
- Strong expertise in mass spectroscopy, NMR and separative sciences (chromatography and crystallization)
- Formulation / Structuration – Biosourced polymers – Functionalization / Chemical modification of polymers – Chemistry / Properties Relationships – Rheology – Stabilization / ageing – Expertise in chemistry and physicochemistry of complex media
A partnership adapted to every stage of R&D
- Consulting and expertise
- Service delivery
- Project engineering
- R&D partnership
- Cifre PhD
- Creation of joint laboratories
- Implementation of national and international collaborative research projects
- Technology transfer
- Hosting researchers and on-site training
Structure description
- An unique entry for better access to all the know-how of this value chain, while facilitating contracting and monitoring of partnerships
- Teams involved into quality endeavours (ISO 9001) aiming at a continuous improvement process for better performances with our industrials partners.
- Scientific consortium of 8 research entities backed by 3 labex (SynOrg, EMC3, Iron) and the Normand Institute of Molecular, Medicinal and Macromolecular Chemistry (INC3M)
- Teams fully integrated into the regional socio-economic fabric (Chemistry Biology Health Technopole, Cosmetic Valley, Polymers Technologies)